The organization of chromatin is crucial for the regulation of gene expression. In particular, both the positioning and properties of nucleosomes influence promoter-specific transcription. The acetylation of core histones has been suggested to alter the properties of nucleosomes and affect the access of DNA-binding transcriptional regulators to promoters. A recently identified mammalian histone deacetylase (HD1) shows homology to the yeast Rpd3 protein, which together with Sin3 affects the transcription of several genes. Mammalian Sin3 proteins interact with the Mad components of the Myc/Max/Mad network of cell growth regulators. Mad/Max complexes may recruit mammalian Rpd3-like enzymes, therefore, directing histone deacetylase activity to promoters and negatively regulating cell growth.
Background
The Myc family of proto-oncoproteins plays a key role in the regulation of cell growth, differentiation and apoptosis (for review, see [1] [2] [3] ). To exert its function, c-Myc has to heterodimerize with Max [4] [5] [6] [7] [8] . Members of the Mad family of proteins also heterodimerize with Max [9] [10] [11] , and so Max is regarded as the central component of the Myc/Max/Mad network. All these proteins belong to the bHLHZip class of DNA-binding molecules, characterized by a basic DNA-binding region and a dimerization domain composed of a helix-loop-helix motif and a leucine zipper motif. The expression pattern and functional characterization of Mad proteins (Mad1, Mxi1, Mad3 and Mad4) suggest that they are negative regulators of cell growth: Mad proteins inhibit the transformation of rat embryo fibroblasts by c-Myc and Ha-Ras, negatively regulate reporter gene transcription, and interfere with S-phase progression [9, [11] [12] [13] [14] [15] [16] . Besides the bHLHZip domain, an amino-terminal domain of the Mad proteins, the Sin3-interaction domain, is essential for these regulatory functions [11, 17, 18] . Sin3 has been shown to interact with Mad proteins and, when expressed as a fusion protein with a DNA-binding domain, to repress gene transcription [19] [20] [21] [22] [23] ; these observations suggest that Sin3 is important for mediating Mad effects, although the molecular basis of this repression is presently unknown.
Chromatin structure is a critical determinant in the regulation of promoter activity [24] [25] [26] . Nucleosomes, which contain approximately 150 base-pairs of DNA wrapped around a core histone octamer, can affect transcription both by their specific positioning on the DNA and by modifications of their histone components. The acetylation of the amino-terminal tails of core histones is an important reversible post-translational modification [25, [27] [28] [29] [30] , and it has been suggested that such acetylation may affect the interaction between histones and DNA, influencing nucleosome compaction. This in turn could regulate the access of proteins to DNA or modify nucleosome mobility. For example, histone acetylation facilitates the binding of TFIIIA to nucleosomal templates [31] , and the removal of the amino termini of core histones by limited proteolysis increases the accessibility of transcription factors to nucleosomes [31, 32] .
Regulation by acetylation is not likely to be a simple quantitative effect. Studies with antibodies that recognize histone H4 acetylated at specific lysine residues have shown that the different isoforms of H4 have distinct patterns of distribution on chromosomes [33] [34] [35] . In addition, different histone acetyltransferases (HATs) have different specificities regarding the histone(s) and the site(s) modified ( [36] [37] [38] and A. Lusser, G. Brosch, G. Lòpez-Rodas and P.L., unpublished observations). These findings indicate that the amino termini of core histones, together with their specific acetylation, play an important role in regulating gene transcription.
The molecular characterization of HATs has strengthened the argument that acetylation is linked to activation of gene transcription. Several proteins that have been identified previously as positive transcriptional regulators also possess HAT activity; these proteins include the transcriptional adaptor protein GCN5, P/CAF, the co-activators CBP and p300, and TAF II 250, a component of the general transcription factor TFIID [37] [38] [39] [40] [41] [42] . HAT activity may therefore be part of, and influence the activity of, the RNA polymerase II holoenzyme. Furthermore, transcription factors such as CREB or c-Myb, which recruit CBP and/or p300 [43] [44] [45] [46] [47] , could bring HATs to promoters and thereby modulate the acetylation pattern of histones, which in turn will alter chromatin structure. This could then affect the accessibility of additional transcription factors to DNA-binding sites, resulting in efficient gene expression.
Whereas a considerable amount of information is available on the functional role of HATs, comparably little has been published on the role of histone deacetylases. A mammalian histone deacetylase (HD1) was identified recently, and the gene has been cloned [48] . The catalytic subunit of this enzyme has 60% identity to the protein encoded by the yeast RPD3 gene [48] . Yeast Rpd3 and Sin3 function in the same genetic pathway for the transcriptional regulation of a number of different genes, and it has been suggested that these two proteins interact directly [29, 49, 50] . Thus, mammalian Sin3 proteins may function as targeting subunits for histone deacetylases, a concept which is consistent with the identification of four paired amphipathic helix (PAH) motifs in Sin3, suggested to provide surfaces for protein-protein interaction [51] . The second PAH motif of Sin3 binds to the Sin3-interaction domain of Mad proteins and of Mnt, a recently identified novel interaction partner of Max, as shown by yeast twohybrid and in vitro analyses [11, 17, 18, 52] .
Three lines of evidence therefore led to the hypothesis that Mad/Max proteins may recruit HD1 via Sin3 in a mammalian system: first, an interaction between Mad1 and Max has been shown previously in vivo [53] ; second, an interaction between Sin3 proteins, encoded by the two related genes sin3A and sin3B, and Mad proteins has been shown in the yeast two-hybrid system and in in vitro interaction assays [11, 17, 18] ; and third, yeast Sin3 and Rpd3 function in the same genetic pathway, suggesting that they interact [29] . Here, we have tested whether Sin3 interacts with the Mad/Max complex in mammalian cells and, furthermore, whether the trimeric complex Max/Mad/Sin3 can recruit HD1. We have identified a Max/Mad/Sin3B/HD1 complex which has histone deacetylase activity. Using colony formation and S-phase progression assays, we show that the recruitment of histone deacetylase activity by Mad/Max is functionally relevant.
Results
In order to determine whether Sin3B interacts with Mad1 in vivo and whether HD1 binds to a Max/Mad1/Sin3B complex, COS7 cells were transiently transfected with cDNAs encoding these four proteins, and complexes were co-immunoprecipitated from whole cell lysates. Using either polyclonal or monoclonal anti-Mad1 antibodies, both Max and Sin3B were identified in the immunoprecipitates ( Fig. 1 and data not shown) . Similarly, Sin3B was detected in anti-Max immunoprecipitates but not in immunoprecipitates using control antibodies (data not shown, see also below). Together, these findings reveal that Sin3B can interact with the Mad1/Max complex in vivo.
The HD1 protein was also detected specifically in antiMad1 immunoprecipitates (Fig. 1) , and these immunoprecipitated complexes contained histone deacetylase activity, as measured by the release of radioactive acetate from histones labelled in vivo (Fig. 2a) . Using the monoclonal antibody 5F4, which recognizes a carboxy-terminal epitope of Mad1 (Fig. 2b,c) , we recovered histone deacetylase activity from cells expressing Max, Mad1, Sin3B and HD1 (Fig. 2a) . In the absence of Mad1, Sin3 or HD1, only little or background histone deacetylase activity was detectable in the immunoprecipitates.
When the cDNA encoding Mad1 was replaced with that encoding Mad1∆N -a variant without the aminoterminal 56 amino acids, a region which includes the Sin3-interaction domain [14] -in the transient transfections, no histone deacetylase activity was co-immunoprecipitated from the cell lysates. This observation is consistent with the role of the Mad1 Sin3-interaction domain in the recruitment of Sin3B. Histone deacetylase activity was co-immunoprecipitated from cells expressing Mad1∆BR -a variant lacking the basic region, responsible for DNAbinding -however, and so the ability to bind to DNA does not appear to be a prerequisite for complex formation (Fig. 2a) . No histone deacetylase activity was detected in immunoprecipitations from cells expressing Mad1∆C, a protein which was not recognized by the anti-Mad monoclonal antibody 5F4 (Fig. 2b,c) . When the monoclonal antibody 5C9, which recognized an amino-terminal epitope of Mad1 (Fig. 2b,c) , was used instead of 5F4, histone deacetylase activity was co-immunoprecipitated from cell lysates expressing Mad1∆C or wild-type Mad1 (Fig. 2a ). These findings demonstrate that Mad1 can associate with functional HD1 in vivo in the presence of Sin3B.
As Mad1 has been shown to form a complex with Max in vivo, we tested whether histone deacetylase activity could be detected in anti-Max immunoprecipitates. When HD1, Max, Mad1 and Sin3B were expressed together, high levels of histone deacetylase activity were detected in the immunoprecipitates (Fig. 3a) . In the absence of Sin3B and/or HD1, low levels of histone deacetylase activity were observed; this activity is likely to be due to the binding of endogenous Sin3B and HD1 or other Rpd3-related enzymes. In contrast, in the absence of Mad1, only background activity was measured, consistent with the low-level expression reported for all known Mad proteins. No activity was found when pre-immune serum was used for the immunoprecipitations. The histone deacetylase activity of the anti-Max immunoprecipitates was completely inhibited in the presence of Na-butyrate or trichostatin A (TSA) (Fig.  3a) , which are inhibitors of histone deacetylases [54] . Thus, our data provide evidence for a cell-derived tetrameric complex composed of Max/Mad1/Sin3B/HD1 which contains histone deacetylase activity, with Sin3B mediating the interaction between Mad1 and HD1.
Max has also been shown to heterodimerize with members of the Mad family other than Mad1, including Mad4 [11] . Histone deacetylase activity was detected in anti-Max immunoprecipitates from cells expressing Mad4 together with Max, Sin3B and HD1 (Fig. 3b) , suggesting that association with HD1 via Sin3B is a general attribute of Mad proteins -consistent with the findings that all Mad proteins contain Sin3-interaction domains and associate with Sin3. The lower levels of histone deacetylase activity in these assays were the result of less efficient expression of Mad proteins, as determined by gel shift analysis (data not shown); this is likely to be due to differences in transfection efficacies.
Mad proteins are potent inhibitors of cell growth. To determine whether Sin3B and HD1 can modulate Mad1 function in vivo, we carried out colony formation assays in Saos-2 cells. The expression of Mad1 alone reduced the number of colonies two-fold, whereas the expression of Mad1Pro -a variant which has a mutation in the Sin3-interaction domain and which does not bind Sin3 [17] had little effect (Fig. 4) . The expression of Sin3B alone (Fig. 4) or HD1 alone (data not shown) did not reduce the number of colonies significantly, whereas the coexpression of Sin3B and HD1 caused a two-fold reduction in the number of colonies. When Sin3B and Mad1 were coexpressed, the inhibitory effect of Mad1 was relieved partially, possibly because the overexpressed Sin3B sequesters endogenous HD1 or Rpd3-related enzymes. However, the inhibitory effect of Mad1 was enhanced by HD1, and, more significantly, by HD1 together with Sin3B. These results suggest that the efficient recruitment of histone deacetylase activity is relevant for the ability of Mad1 to inhibit cell growth. By contrast, the combination of Mad1Pro, Sin3 and HD1 did not show higher inhibition than Sin3B and HD1 alone, emphasizing the importance of the interaction between Mad1 and Sin3B/HD1. inhibitory effect until late in G1. Therefore we tested whether histone deacetylase activity was required for S-phase inhibition. Resting NIH3T3-L1 cells microinjected with Mad1-expression plasmids were stimulated with serum and were treated in mid-G1 with or without TSA. Whereas more than 90% of Mad1-expressing cells were unable to enter S-phase, TSA treatment resulted in a significant fraction of Mad1-positive cells that were able to progress into S-phase (Fig. 5) . TSA had no effect on S-phase entry of control cells under the conditions used. This finding suggests that histone deacetylase activity is important for Mad1 to block progression into S-phase, consistent with the observation that Mad1∆N, which lacks the Sin3-interaction domain, does not inhibit entry into S-phase (A.M., J. Mertsching, S.H., A.S., C. Cerni, M. Henriksson and B.L., unpublished observations).
Discussion
Here, we have shown that the Mad1/Max complex interacts with Sin3B in vivo, and that the Max/Mad1/Sin3B trimeric complex can bind HD1. This tetrameric complex has histone deacetylase activity. We have therefore established a link between sequence-specific DNA-binding proteins and a histone deacetylase. The effects of Sin3B and HD1 on the ability of Mad1 to inhibit colony formation, and of TSA to overcome the Mad1-induced S-phase block, provide evidence for the biological relevance of histone deacetylase recruitment by Mad proteins. We suggest that the negative regulation of cell growth by Mad proteins is, at least in part, the result of bringing histone deacetylase activity to promoters, which in turn leads to structural and/or functional alterations of nucleosomes and ultimately to Mad-specific repression of gene transcription.
The available evidence suggests that Myc proteins affect cell growth by regulating the expression of specific genes [3] . The antagonistic effects of Mad proteins on Myc function may therefore at least in part involve the modulation of the same genes. Whereas Myc activates the expression of genes which contain Myc-specific E-boxes, Mad proteins may inhibit such genes. The recruitment of histone deacetylase activity, as well as other lines of evidence (for discussion, see [3] ), suggest that the transcriptional repression mediated by Mad is not likely to result from simple competition between Myc/Max and Mad/Max complexes for binding sites. Rather, by attracting histone deacetylase activity to a promoter, histone deacetylation and compaction of chromatin may lead to a dominant inhibition of transcription [22] . At present, this scenario is hypothetical because no gene has been identified which is repressed by Mad. So far, only the expression of a synthetic reporter gene construct has been shown to be inhibited by Mad in transient transfection experiments [9, 11] . It is unclear whether regularly positioned nucleosomes are formed on The tetrameric Max/Mad/Sin3B/HD1 complex possesses histone deacetylase activity. COS7 cells were transfected with expression plasmids for the indicated proteins and subsequently lysed in Frackelton buffer. (a) Anti-Max and anti-Sin3B, but not pre-immune (pre-im) serum immunoprecipitates, contain histone deacetylase activity. Anti-HD1 immunocomplexes also possessed histone deacetylase activity (data not shown). The recruitment of histone deacetylase activity in anti-Max immunoprecipitates was dependent on the co-expression of both Mad1 and Sin3B. Histone deacetylase activity was inhibited by the addition of either sodium butyrate or trichostatin A (TSA). (b) Mad4 can mediate the association of histone deacetylase activity with Max. transfected reporter gene constructs under such conditions [55, 56] , and so histone deacetylase activity may not be important for this type of repression; however, Mad proteins without the Sin3-interaction domain are not able to repress, suggesting that binding to Sin3 is still required. As Sin3 has multiple domains for potential protein-protein interactions, other proteins besides HD1 may be recruited and may lead to inhibition of transcription. Thus, it will be of utmost importance to identify Mad-regulated genes to test the predictions made here.
+ + + ----+ + + + + + + -+ + + + --------+ ---------------------+ -
Our functional data are consistent with the concept that such Mad-regulated genes exist and that histone deacetylase activity is relevant for the regulation of these genes by Mad proteins (Figs 4,5) . However, the modulation of histone deacetylase activity in cells is likely to have many different effects. Until specific Mad target genes can be analysed and the role of histone deacetylase activity determined in vivo, firm statements are difficult to make. The use of TSA has clearly demonstrated that histone deacetylase activity is important for cell growth [54] . It has been shown that treatment with TSA results in a reversible inhibition of cell growth by inducing a G1 and a G2 arrest [57] . Consistent with this finding, we have also observed that TSA can block S-phase entry of serumstimulated fibroblasts when the drug is added concomitantly with serum (data not shown). Therefore we have treated our cells between 7-10 hours after serum addition with TSA. At this time, the cells are in mid to late G1 with the first cells entering S-phase 11 hours after serum addition (data not shown). As the control cells were not affected by this treatment, histone deacetylase activity does not seem to be crucial for the G1-to-S phase transition. However, the Mad1-induced block can be overcome, at least in part, by TSA treatment, suggesting that, for the S-phase inhibiting function of Mad1, histone deacetylase activity is necessary until late in G1. Together with our finding that Mad1 inhibits entry into S-phase until late in G1 (A.M., J. Mertsching, S.H., A.S., C. Cerni, M. Henriksson and B.L., unpublished observations), it is possible that genes which regulate the G1-to-S phase progression of the cell cycle or their regulators are the target of Mad1 action.
The recruitment of histone deacetylase activity to a specific promoter through sequence-specific transcription factors could influence the local acetylation status of core histones. Several different models have been proposed for the mechanism that links differential acetylation of the amino-terminal tails of core histones to effects on gene transcription [25] . These models include effects on histone-DNA interaction, which may alter nucleosome compaction and thereby regulate the access of proteins to DNA or modify nucleosome mobility. Thus, a decreased accessibility of other transcriptional regulators to a specific promoter region could result in a dominant repression of gene expression. The interaction of proteins with histones may also be regulated by the degree and the specific pattern of acetylation of histone tails. It has been shown that the yeast silent information regulators Sir3 and Sir4 can bind to the amino termini of histone H3 and H4 [58] . Recruitment of such proteins could lead to the formation of heterochromatin on larger chromosomal regions and affect the expression of multiple genes.
Sin3 proteins appear to function as adaptors that target HD1 to Mad/Max complexes, but other targeting subunits for HD1 may also exist. During the purification of this enzyme, one subunit was identified as RbAp48, a protein characterized previously as an interaction partner of the retinoblastoma protein p105 Rb [48, 59] . Thus, RbAp48 may recruit HD1 to p105 Rb , which itself binds to the E2F class of transcriptional regulators. E2Fs are important modulators of the cell cycle and several different genes regulated by these proteins have been identified [60] [61] [62] . It has been suggested that p105 Rb not only inhibits the transactivation function of E2F factors but also represses actively [63, 64] . The dominant repressing effect exerted by the E2F-p105 Rb complex on the expression of genes containing E2F-binding sites may be the consequence of recruiting histone deacetylase activity. Together, these findings suggest that, through adaptor proteins and sequencespecific transcription factors, HD1 and possibly other histone deacetylases can be brought to specific genes and influence their expression.
Conclusions
Accumulating evidence suggests that histone acetylation plays an important role in the regulation of gene transcription. With the identification and characterization of HATs and histone deacetylases, the enzymes involved can now be studied. An important question is how HATs and histone deacetylases are targeted to specific promoters.
Here, we provide evidence for a complex composed of the sequence-specific DNA-binding complex Mad/Max, the adaptor Sin3B and the histone deacetylase HD1. This complex possesses histone deacetylase activity and appears to be of functional relevance. Our findings also imply that active HD1 can be targeted to promoters that contain Myc E-boxes.
Materials and methods

Expression plasmids
The plasmids pSP-max p22, pSP-mad1, pCMV-mad1, pCMV-mad1∆N and pCMV-mad1∆C have been described previously [14] ; pSPmad1∆BR, pSP-mad1Pro and pSP-mad4 were provided by R. Eisenman and the mad coding regions were subcloned into the pCMV vector. A murine cDNA encoding HD1 was cloned as an interleukin-2 inducible gene (S. Bartl, J. Taplick, G. Lagger, H. Khier, K. Kuchler and C.S., unpublished). Murine HD1 has 99% identity to human HD1, 84% to murine Rpd3 and 58% to yeast RPD3 ( [48, 49, 65] and S. Bartl, J. Taplick, G. Lagger, H. Khier, K. Kuchler and C.S., unpublished). HD1 was tagged with a Myc epitope (9E10) and cloned into pCMV or pBabe vectors (S. Bartl, J. Taplick, G. Lagger, H. Khier, K. Kuchler and C.S., unpublished). A cDNA encoding murine Sin3B (from R. Eisenman) was cloned into pCMV. The expression of all constructs was verified by western blotting and by immunoprecipitation (see Fig. 1 and data not shown).
Cell culture and transfections
COS7, Saos-2 and NIH3T3-L1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS at 37°C, 5% CO 2 . Transfections were carried out using the calcium phosphate coprecipitation technique [66] . For the colony formation assays, a total of 20 g of the indicated combinations of expression plasmids (pSP-mad1, pSP-mad1Pro, pBabe-HD1, pCMV-sin3B) or the respective control vectors were transfected into Saos-2 cells together with a neomycin resistance plasmid. For each individual experiment, cell cultures were split into at least triplicate dishes after 24 h. After 48 h, 0.5 g ml -1 G418 was added and colonies were stained after 30 days.
Antibodies
Monoclonal antibodies were generated by immunizing Wistar rats with a bacterially expressed glutathione-S-transferase-Mad1 fusion protein.
Monoclonal antibodies 5C9 and 5F4 recognize Mad1 specifically. The polyclonal anti-Max serum 85 and the corresponding pre-immune serum have been described previously [14] . The antiserum recognizing HD1 will be described elsewhere (S. Bartl, J. Taplick, G. Lagger, H. Khier, K. Kuchler and C.S., unpublished). Polyclonal antibodies recognizing Mad1 and Sin3B were purchased from Santa Cruz (C-19 and AK12, respectively). Rabbit anti-mouse antibodies and Cy 3 -labelled secondary antibodies were from Jackson Immuno Research Laboratories. An FITC-coupled monoclonal antibody recognizing BrdU was obtained from Boehringer Mannheim.
Metabolic labelling and immunoprecipitations
For metabolic labelling, COS7 cells were transiently transfected with pCMV-expression plasmids. Cells were labelled in methionine/cysteinefree medium with 0.3 mCi 35 S-Met/Cys-Translabel (ICN) per ml for 40 min at 37°C. The cells were then lysed in Frackelton buffer (10 mM Tris-HCl, pH 7.05, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 5 M ZnCl 2 , 100 M Na 3 VO 4 , 1% Triton X-100, 1 mM PMSF, 5 U ml -1 ␣ 2 -macroglobulin, 2.5 U ml -1 pepstatin, 2.5 U ml -1 leupeptin, 0.15 mM benzamidin, 2.8 g ml -1 aprotinin), vortexed and cleared by centrifugation. Max was immunoprecipitated with the polyclonal serum 85, Mad1 with the polyclonal antibody C-19 or with monoclonal antibodies 5C9 or 5F4, Sin3B with the polyclonal antibody AK12 and HD1 with a polyclonal serum, as described [67] . Briefly, for direct immunoprecipitations, protein complexes were collected with protein Aor protein G-Sepharose and washed under high stringent conditions:
Research Paper Recruitment of HD1 by Mad/Max via Sin3 Sommer et al. 363 Trichostatin A (TSA) was added 7-10 h after serum stimulation. Cells started to enter S-phase 11 h after addition of serum and more than 90% were BrdU-positive by 18 h (data not shown). twice with RIPA buffer (10 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 1% deoxycholate, 0.1% SDS, 0.5% aprotinin), once with high salt buffer (10 mM Tris pH 7.4, 2 M NaCl, 1% NP-40, 0.5% deoxycholate) and finally with RIPA buffer. For co-immunoprecipitations, Mad1-containing protein complexes were precipitated under low-stringent conditions in Frackelton buffer. Co-immunoprecipitated proteins were released in AB buffer (20 mM Tris pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate, 0.5% SDS, 0.5% aprotinin, 0.5% phenylmethylsulfonyl fluoride) and reprecipitated after a four-fold dilution into Frackelton buffer. The immunocomplexes were washed under high-stringent conditions as described above, boiled in sample buffer, separated by 12.5% SDS-PAGE and visualized using a Phosphoimager.
Western blotting and electrophoretic mobility shift assays
The conditions for Western blotting have been described previously [68] . The electrophoretic mobility shift assays will be reported elsewhere (A.S., K. Bousset, E.K., M. Austen and B.L., unpublished observations). The CMD oligonucleotide has been described [69] .
Immunoprecipitation-histone deacetylase assay
COS7 cells transiently transfected with pCMV constructs (except for a pSP construct to express Max) were lysed in Frackelton buffer and precleared by centrifugation. The expression levels of the different Mad proteins in these lysates were analysed by gel shift assays (data not shown). Protein A-or protein G-Sepharose beads were incubated with the respective antibodies prior to the addition of cell lysate (the equivalent of 1/5 of a 10 cm dish). After incubation at 4°C for 1 h, the immunocomplexes were washed twice in Frackelton buffer and once in histone deacetylase assay buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10% v/v glycerol) [48] . The reactions were carried out in 30 l histone deacetylase assay buffer containing approximately 7.5 g of in vivo [ 3 H]-acetate-labelled chicken reticulocyte core histones (corresponding to approximately 5000-6000 cpm) [70, 71] at 37°C for 2 h. The reactions were stopped with 0.4M acetate/1M HCl and [ 3 H]-acetate was extracted with 1 ml ethylacetate and aliquots were counted [72] . Where indicated, the reactions were performed in the presence of either 2 mM Na-butyrate (Fluka) or 20 nM Trichostatin A (Wako Chemicals GmbH). The basal histone deacetylase activity using either lysates of untransfected cells or control antibodies resulted in the release of 80-130 cpm.
Microinjection
NIH3T3-L1 cells were grown on glass cover slips and serum-starved for 36 h. Cells were then microinjected with pCMV-mad1 and stimulated by the addition of serum in the presence of 100 M bromodeoxyuridine. Progression into S-phase was monitored by anti-BrdU immunostaining. Mad1-expressing cells were identified by staining with antibody C-19. Trichostatin A (50 nM) was added 7-10 h after serum addition.
